Article
Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Journal of clinical laboratory analysis - 1 Nov 2017
Bingül İlknur, Vural Pervin, Doğru-Abbasoğlu Semra, Çil Esra, Uysal Müjdat
Abstract excerpt
BACKGROUND: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Vascular endothelial growth factor (VEGF) is a mediator implicated with cell proliferation, differentiation and migration, and monocyte/macrophage chemotaxis. In present study, we aimed to investigate the relat...
Topics
- Adult
- Carcinoma, Papillary
- Case-Control Studies
- Female
- Genetic Predisposition to Disease
- Genotype
- Humans
- Linkage Disequilibrium
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Thyroid Cancer, Papillary
- Thyroid Neoplasms
- Vascular Endothelial Growth Factor A
